The index comprised ratios and differences of three tumor markers (CA19-9, CEA, and DUPAN-2), along with the tumor diameter on computed tomography (CT) images at the initiation of treatment, after neoadjuvant therapy, and after surgery. The gene discussed is CEACAM5; the disease is neoplasm.